Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

National Research (NRC) EBITDA Margin: 2010-2025

Historic EBITDA Margin for National Research (NRC) over the last 16 years, with Q3 2025 value amounting to 22.36%.

  • National Research's EBITDA Margin rose 800.0% to 22.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.78%, marking a year-over-year decrease of 61100.0%. This contributed to the annual value of 24.6% for FY2024, which is 23500.0% down from last year.
  • Latest data reveals that National Research reported EBITDA Margin of 22.36% as of Q3 2025, which was up 800.0% from 4.67% recorded in Q2 2025.
  • In the past 5 years, National Research's EBITDA Margin ranged from a high of 34.79% in Q3 2021 and a low of 4.67% during Q2 2025
  • Moreover, its 5-year median value for EBITDA Margin was 26.24% (2023), whereas its average is 27.23%.
  • As far as peak fluctuations go, National Research's EBITDA Margin surged by 43200bps in 2021, and later crashed by -206500bps in 2025.
  • Quarter analysis of 5 years shows National Research's EBITDA Margin stood at 33.62% in 2021, then decreased by -5bps to 32.09% in 2022, then dropped by -4bps to 30.81% in 2023, then dropped by -16bps to 25.98% in 2024, then dropped by -14bps to 22.36% in 2025.
  • Its last three reported values are 22.36% in Q3 2025, 4.67% for Q2 2025, and 25.62% during Q1 2025.